|
1
|
Bamodu OA, Kuo KT, Yuanc LP, et al: HDAC
inhibitor suppresses proliferation and tumorigenicity of
drug-resistant chronic myeloid leukemia stem cells through
regulation of hsa-miR-196a targeting BCR/ABL1. Exp Cell Res.
370:519–530. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhou H, Mak PY, Mu H, Mak DH, Zeng Z,
Cortes J, Liu Q, Andreeff M and Carter BZ: Combined inhibition of
β-catenin and Bcr-Abl synergistically targets tyrosine kinase
inhibitor-resistant blast crisis chronic myeloid leukemia blasts
and progenitors in vitro and in vivo. Leukemia. 31:2065–2074. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Xiao X, Liu P, Li D, Xia Z, Wang P, Zhang
X, Liu M, Liao L, Jiao B and Ren R: Combination therapy of
BCR-ABL-positive B cell acute lymphoblastic leukemia by tyrosine
kinase inhibitor dasatinib and c-JUN N-terminal kinase inhibition.
J Hematol Oncol. 13:802020. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Deshpande A and Buske C: Knocking the Wnt
out of the sails of leukemia stem cell development. Cell Stem Cell.
1:597–598. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zovko A, Yektaei-Karin E, Daniel S,
Nilsson A, Wallvik J and Stenke L: Montelukast, a cysteinyl
leukotriene receptor antagonist, inhibits the growth of chronic
myeloid leukemia cells through apoptosis. Oncol Rep. 40:902–908.
2018.PubMed/NCBI
|
|
6
|
Braun TP, Eide CA and Druker BJ: Response
and resistance to BCR-ABL1-targeted therapies. Cancer Cell.
37:530–542. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Vetrie D, Helgason GV and Copland M: The
leukaemia stem cell: Similarities, differences and clinical
prospects in CML and AML. Nat Rev Cancer. 20:158–173. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kumar R, Pereira RS, Zanetti C, et al:
Specific, targetable interactions with the microenvironment
influence imatinib-resistant chronic myeloid leukemia. Leukemia.
34:2087–2101. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cronan TA, Kaplan RM, Posner L, Blumberg E
and Kozin F: Prevalence of the use of unconventional remedies for
arthritis in a metropolitan community. Arthritis Rheum.
32:1604–1607. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
AlGhamdi KM, Khurrum H, Al-Natour SH, et
al: Use of complementary and alternative medicine among dermatology
outpatients: Results from a national survey. J Cutan Med Surg.
19:570–579. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wu L, Yu J, Chen R, Liu Y, Lou L, Wu Y,
Huang L, Fan Y, Gao P, Huang M, et al: Dual inhibition of Bcr-Abl
and Hsp90 by C086 potently inhibits the proliferation of
imatinib-resistant CML cells. Clin Cancer Res. 21:833–843. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ryan NM, Vertigan AE and Birring SS: An
update and systematic review on drug therapies for the treatment of
refractory chronic cough. Expert Opin Pharmacother. 19:687–711.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tsai WJ, Yang SC, Huang YL, Chen CC,
Chuang KA and Kuo YC: 4-Hydroxy-17-methylincisterol from Agaricus
blazei decreased cytokine production and cell proliferation in
human peripheral blood mononuclear cells via inhibition of NF-AT
and NF-κB activation. Evid Based Complement Alternat Med.
2013:4359162013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hetland G, Tangen JM, Mahmood F, et al:
Antitumor, anti-inflammatory and antiallergic effects of
Agaricus blazei mushroom Extract and the related medicinal
Basidiomycetes mushrooms, Hericium erinaceus and Grifola
frondosa: A review of preclinical and clinical studies.
Nutrients. 12:13392020. View Article : Google Scholar
|
|
15
|
Li Y, Sheng Y, Lu X, Guo X, Xu G, Han X,
An L and Du P: Isolation and purification of acidic polysaccharides
from Agaricus blazei Murill and evaluation of their lipid-lowering
mechanism. Int J Biol Macromol. 157:276–287. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sun YQ, Guo TK, Xi YM, Chen C, Wang J and
Wang ZR: Effects of AZT and RNA-protein complex (FA-2-b-β)
extracted from Liang Jin mushroom on apoptosis of gastric cancer
cells. World J Gastroenterol. 13:4185–4191. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lin MH, Lee KM, Hsu CY, et al:
Immunopathological effects of Agaricus blazei Murill
polysaccharides against Schistosoma mansoni infection by Th1 and
NK1 cells differentiation. Int Immunopharmacol. 73:502–514. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ziliotto L, Pinheiro F, Barbisan LF and
Rodrigues MAM: Screening for in vitro and in vivo antitumor
activities of the mushroom Agaricus Blazei. Nutr Cancer.
61:245–250. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Pak S, Park S, Kim Y, et al: Correction
to: The small molecule WNT/β-catenin inhibitor CWP232291 blocks the
growth of castration-resistant prostate cancer by activating the
endoplasmic reticulum stress pathway. J Exp Clin Cancer Res.
38:4402019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lin HJ, Huang Y, Huang WL, Feng XL, Peng
Y, Zhang XJ, Jin Z and Fan XM: Regulatory mechanism of microRNA and
Wnt/β-catenin signaling pathway in tumorigenesis and metastasis.
Sci Sin. 45:5–14. 2018.
|
|
21
|
Li ZJ, Qiu LG, Li X, et al: Expression of
β-catenin gene in CML and its relationship with bcr/abl. J Exp
Hematol. 15:931–935. 2007.(In Chinese).
|
|
22
|
Hu Y, Yu K, Wang G, Zhang D, Shi C, Ding
Y, Hong D, Zhang D, He H, Sun L, et al: Lanatoside C inhibits cell
proliferation and induces apoptosis through attenuating
Wnt/β-catenin/c-Myc signaling pathway in human gastric cancer cell.
Biochem Pharmacol. 150:280–292. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mizuno T, Inagaki R, Kanao T, Hagiwara T,
Nakamura T, Ito H, Shimura K, Sumiya T and Asakura A: Antitumor
activity and some properties of water-insoluble hetero-glycans from
‘Himematsutake’, the fruiting body of Agaricus blazei
Murill. Agr Biol Chem. 54:2897–2905. 1990. View Article : Google Scholar
|
|
24
|
Dong S, Furutani Y, Suto Y, Furutani M,
Zhu Y, Yoneyama M, Kato T, Itabe H, Nishikawa T, Tomimatsu H, et
al: Estrogen-like activity and dual roles in cell signaling of an
Agaricus blazei Murrill mycelia-dikaryon extract. Microbiol Res.
167:231–237. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
He B, Wang Q, Liu X, et al: A novel HDAC
inhibitor chidamide combined with imatinib synergistically targets
tyrosine kinase inhibitor resistant chronic myeloid leukemia cells.
Biomed Pharmacother. 129:1103902020. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tang K and Lightner DV: Detection and
quantification of infectious hypodermal and hematopoietic necrosis
virus in penaeid shrimp by real-time PCR. Dis Aquat Organ.
44:79–85. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chen SH, Hsieh YY, Tzeng HE, et al: ABL
genomic editing sufficiently abolishes oncogenesis of human chronic
myeloid leukemia cells in vitro and in vivo. Cancers (Basel).
12:13992020. View Article : Google Scholar
|
|
28
|
Ryu H, Nam KY, Kim JS, Hwang SG, Song JY
and Ahn J: The small molecule AU14022 promotes colorectal cancer
cell death via p53-mediated G2/M-phase arrest and
mitochondria-mediated apoptosis. J Cell Physiol. 233:4666–4676.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sun S, Zhang C, Gao J, Qin Q, Zhang Y, Zhu
H, Yang X, Yang D and Yan HT: Benzoquinone induces ROS-dependent
mitochondria-mediated apoptosis in HL-60 cells. Toxicol Ind Health.
34:270–281. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Taofiq O, Rodrigues F, Barros L, et al:
Agaricus blazei Murrill from Brazil: an ingredient for
nutraceutical and cosmeceutical applications. Food Funct.
10:565–572. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang H, Fu Z and Han C: The medicinal
values of culinary-medicinal royal sun mushroom (Agaricus blazei
Murrill). Evid Based Complement Alternat Med. 2013:8426192013.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wu S, Li F, Jia S, et al: Drying effects
on the antioxidant properties of polysaccharides obtained from
Agaricus blazei Murrill. Carbohydr Polym. 103:414–417. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhang F, Song X, Li L, Wang J, Lin L, Li
C, Li H, Lv Y, Jin Y, Liu Y, et al: Polygala tenuifolia
polysaccharide PTP induced apoptosis in ovarian cancer cells via a
mitochondrial pathway. Tumor Biol. 36:2913–2919. 2015. View Article : Google Scholar
|
|
34
|
Schultz DR and Harringto WJ: Apoptosis:
Programmed cell death at a molecular level. Semin Arthritis Rheum.
32:345–369. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Mondal A, Banerjee D, Majumder R, Maity TK
and Khowala S: Evaluation of in vitro antioxidant, anticancer and
in vivo antitumour activity of Termitomyces clypeatus MTCC 5091.
Pharm Biol. 54:2536–2546. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Hou YC, Chao YJ, Tung HL, Wang HC and Shan
YS: Coexpression of CD44-positive/CD133-positive cancer stem cells
and CD204-positive tumor-associated macrophages is a predictor of
survival in pancreatic ductal adenocarcinoma. Cancer.
120:2766–2777. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wu Q, Yang Y, Wu S, et al: Evaluation of
the correlation of KAI1/CD82, CD44, MMP7 and β-catenin in the
prediction of prognosis and metastasis in colorectal carcinoma.
Diagn Pathol. 10:1762015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yao H, Ashihara E and Maekawa T: Targeting
the Wnt/β-catenin signaling pathway in human cancers. Expert Opin
Ther Targets. 15:873–887. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Collin-Hansen C, Pedersen SA, Andersen RA
and Steinnes E: First report of phytochelatins in a mushroom:
induction of phytochelatins by metal exposure in Boletus edulis.
Mycologia. 99:161–174. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Saadeddin A, Babaei-Jadidi R, Spencer-Dene
B and Nateri A: The links between Transcription, -catenin/JNK
signaling, and carcinogenesis. Mol Cancer Res. 7:1189–1196. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Gan X, Wang J, Xi Y, Wu Z, Li Y and Li L:
Nuclear Dvl, c-Jun, beta-catenin, and TCF form a complex leading to
stabilization of beta-catenin-TCF interaction. J Cell Biol.
180:1087–1100. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Lepourcelet M, Chen YNP, France DS, et al:
Small-molecule antagonists of the oncogenic Tcf/beta-catenin
protein complex. Cancer Cell. 5:91–102. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Silverberg E and Lubera J: Cancer
statistics, 1987. CA Cancer J Clin. 37:2–19. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Chairoungdua A, Smith DL, Pochard P, Hull
M and Caplan MJ: Exosome release of β-catenin: A novel mechanism
that antagonizes Wnt signaling. J Cell Biol. 190:1079–1091. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Kim JS, Crooks H, Foxworth A and Waldman
T: Proof-of-principle: Oncogenic β-catenin is a valid molecular
target for the development of pharmacological inhibitors 1. Mol
Cancer Ther. 1:1355–1359. 2002.PubMed/NCBI
|
|
46
|
Liu N, Zang S, Liu Y, et al: FZD7
regulates BMSCs-mediated protection of CML cells. Oncotarget.
7:6175–6187. 2015. View Article : Google Scholar
|
|
47
|
Iwasaki H and Akashi K: Identification and
biology of CML stem cells. Springer; Japan: 2016,
doi:10.1007/978-4-431-55714-2_1. View Article : Google Scholar
|
|
48
|
Sun J, Li B, Jia Z, Zhang A, Wang G, Chen
Z, Shang Z, Zhang C, Jian C and Yang W: RUNX3 inhibits glioma
survival and invasion via suppression of the β-catenin/TCF-4
signaling pathway. J Neurooncol. 140:15–26. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Hoffmann VS, Hasford J, Deininger M,
Cortes J, Baccarani M and Hehlmann R: Systematic review and
meta-analysis of standard-dose imatinib vs. high-dose imatinib and
second generation tyrosine kinase inhibitors for chronic myeloid
leukemia. J Cancer Res Clin Oncol. 143:1311–1318. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Ge L, Tian JH, Li YN, Pan JX, Li G, Wei D,
Xing X, Pan B, Chen YL, Song FJ, et al: Association between
prospective registration and overall reporting and methodological
quality of systematic reviews: A meta-epidemiological study. J Clin
Epidemiol. 93:45–55. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Tian J, Zhang J, Ge L, Yang K and Song F:
The methodological and reporting quality of systematic reviews from
China and the USA are similar. J Clin Epidemiol. 85:50–58. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Sun J, Li B, Jia Z, Zhang A, Wang G, Chen
Z, Shang Z, Zhang C, Cui J and Yang W: RUNX3 inhibits glioma
survival and invasion via suppression of the β-catenin/TCF-4
signaling pathway. J Neurooncol. 140:15–26. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Liu ZL, Hu J, Huang ZL, Li H, Liu Y and
Feng WL: Influence of AKT inhibitor on Wnt/β-catenin pathway in
chronic myeloid leukemia K562 cells. Medical Journal of Chinese
People's Liberation Army. 40:710–715. 2015.
|
|
54
|
Zhang L, Xu J, Zhang X, Zhang Y, Wang L,
Huang X and Xu Z: The role of tumoral FOXP3 on cell proliferation,
migration, and invasion in gastric cancer. Cell Physiol Biochem.
42:1739–1754. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Srivastava R, Cao Z, Nedeva C, et al:
BCL-2 family protein BOK is a positive regulator of uridine
metabolism in mammals. Proc Natl Acad Sci USA. 116:15469–15474.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Tajadura V, Hansen MH, Smith J, et al:
β-catenin promotes endothelial survival by regulating eNOS activity
and flow-dependent anti-apoptotic gene expression. Cell Death Dis.
11:4932020. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Liang J, Wang W, Wei L, Gao S and Wang Y:
Oridonin inhibits growth and induces apoptosis of human neurocytoma
cells via the Wnt/β-catenin pathway. Oncol Lett. 16:3333–3340.
2018.PubMed/NCBI
|
|
58
|
Sumiya T, Ikeda Y, Broadmeadow A, May K,
Pritchard L, Horne C and Burlinson B: Himematsutake (Iwade Strain
101) extract (ABM-FD): Genetic toxicology and a 3-month dietary
toxicity study in rats. Food Chem Toxicol. 46:1949–1959. 2008.
View Article : Google Scholar : PubMed/NCBI
|
